Turn Therapeutics (TTRX) Interest & Investment Income (2024 - 2026)
Turn Therapeutics' (TTRX) quarterly Interest & Investment Income came in at $49679.0 in Q1 2026, up 861.84% year-on-year from $5165.0 in Q1 2025, and up 250.47% quarter-over-quarter from $14175.0 in Q4 2025.
Turn Therapeutics (TTRX) Interest & Investment Income (2024 - 2026) Analysis & Trends
Turn Therapeutics' Interest & Investment Income history runs 3 years deep, the most recent figure standing at $49679.0 for Q1 2026.
- On a quarterly basis, Interest & Investment Income rose 861.84% year-over-year to $49679.0 in Q1 2026; TTM through Mar 2026 was $74130.0, a N/A change from a year earlier, with the FY2025 full-year figure at $29583.0, up 3.04% from the prior year.
- Interest & Investment Income advanced to $49679.0 in Q1 2026 per TTRX's latest filing, from $14175.0 in the prior quarter.
- Across five years, Interest & Investment Income topped out at $49679.0 in Q1 2026 and bottomed at $5111.0 in Q3 2025.
- The 3-year median for Interest & Investment Income is $6188.5 (2024), against an average of $14417.8.
- Across the five-year window, Interest & Investment Income fell 21.97% in 2025 and soared 861.84% in 2026, its largest moves.
- Year by year, Interest & Investment Income stood at $5827.0 in 2024, then jumped by 143.26% to $14175.0 in 2025, then jumped by 250.47% to $49679.0 in 2026.
- Per Business Quant, the three latest TTRX Interest & Investment Income figures stand at $49679.0 (Q1 2026), $14175.0 (Q4 2025), and $5111.0 (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | - |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 27.66 Mn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 114.80 Mn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | -65.80 Mn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | 44.00 Mn |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | 19.51 Mn |
| 10 | Turn Therapeutics | 253.20 Mn | 253.20 Mn | - | 49,679.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 49,679.00 |
| Dec 31, 2025 | 14,175.00 |
| Sep 30, 2025 | 5,111.00 |
| Mar 31, 2025 | 5,165.00 |
| Dec 31, 2024 | 5,827.00 |
| Sep 30, 2024 | 6,550.00 |